Cargando…
Outcomes of catheter-directed thrombolysis vs. standard medical therapy in patients with acute submassive pulmonary embolism
BACKGROUND: Catheter-directed thrombolysis (CDL) is increasingly being used for the treatment of submassive and massive pulmonary embolism. Although this therapy has been shown to be effective at reducing right ventricle strain, the impact on clinical outcomes remains unclear. We therefore aimed to...
Autores principales: | D’Auria, Stephen, Sezer, Ahmet, Thoma, Floyd, Sharbaugh, Michael, McKibben, Jeffrey, Maholic, Robert, Avgerinos, Efthymios D., Rivera-Lebron, Belinda N., Toma, Catalin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144676/ https://www.ncbi.nlm.nih.gov/pubmed/32292583 http://dx.doi.org/10.1177/2045894019898368 |
Ejemplares similares
-
Apixaban or Rivaroxaban Versus Warfarin for Treatment of Submassive Pulmonary Embolism After Catheter-Directed Thrombolysis
por: Groetzinger, Lara M., et al.
Publicado: (2018) -
Catheter-Directed Thrombolysis for Submassive Pulmonary Embolism in the Third Trimester of Pregnancy
por: Compadre, Amanda J., et al.
Publicado: (2020) -
Catheter-directed therapy for submassive pulmonary embolism after unsuccessful systemic thrombolysis
por: Dong, Chang, et al.
Publicado: (2017) -
Low-dose thrombolysis for submassive pulmonary embolism
por: Yilmaz, Emine Serap, et al.
Publicado: (2021) -
Catheter-directed Thrombolysis versus Systemic Anticoagulation for Submassive Pulmonary Embolism: A Meta-Analysis
por: Siordia, Juan Arturo, et al.
Publicado: (2022)